155 related articles for article (PubMed ID: 16735794)
21. Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.
Praktiknjo M; Trebicka J; Carnevale R; Pastori D; Queck A; Ettorre E; Violi F
Clin Transl Gastroenterol; 2020 Feb; 11(2):e00123. PubMed ID: 32032127
[TBL] [Abstract][Full Text] [Related]
22. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
23. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
[TBL] [Abstract][Full Text] [Related]
24. High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.
Kamphuisen PW; Eikenboom JC; Rosendaal FR; Koster T; Blann AD; Vos HL; Bertina RM
Br J Haematol; 2001 Oct; 115(1):156-8. PubMed ID: 11722428
[TBL] [Abstract][Full Text] [Related]
25. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
26. [Portal vein thrombosis in children: clinical and laboratory study of 26 cases].
Yamada RM; Antunes MM; Cardoso SR; Servidoni Mde F; Hessel G
Arq Gastroenterol; 1999; 36(1):49-53. PubMed ID: 10511880
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.
Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA;
Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481
[TBL] [Abstract][Full Text] [Related]
28. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
[TBL] [Abstract][Full Text] [Related]
29. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
Denninger MH; Chaït Y; Casadevall N; Hillaire S; Guillin MC; Bezeaud A; Erlinger S; Briere J; Valla D
Hepatology; 2000 Mar; 31(3):587-91. PubMed ID: 10706547
[TBL] [Abstract][Full Text] [Related]
30. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
31. [High concentration of coagulation factor VIII as a risk factor for thrombosis].
Kamphuisen PW; Eikenboom HC; Rosendaal FR; Bertina RM
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2213-7. PubMed ID: 11757243
[TBL] [Abstract][Full Text] [Related]
32. Portomesenteric venous thrombosis associated with rectal venous malformations.
Kulungowski AM; Fox VL; Burrows PE; Alomari AI; Fishman SJ
J Pediatr Surg; 2010 Jun; 45(6):1221-7. PubMed ID: 20620324
[TBL] [Abstract][Full Text] [Related]
33. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen and von Willebrand Factor.
Coca M; Cucuianu M; Hâncu N
Rom J Intern Med; 2005; 43(1-2):115-26. PubMed ID: 16739871
[TBL] [Abstract][Full Text] [Related]
34. Factor VIII: von Willebrand factor patterns in the plasma of patients with pre-eclampsia.
Calvin S; Corrigan J; Weinstein L; Jeter M
Am J Perinatol; 1988 Jan; 5(1):29-32. PubMed ID: 3122779
[TBL] [Abstract][Full Text] [Related]
35. Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia.
Livesey JA; Manning RA; Meek JH; Jackson JE; Kulinskaya E; Laffan MA; Shovlin CL
Thorax; 2012 Apr; 67(4):328-33. PubMed ID: 22169361
[TBL] [Abstract][Full Text] [Related]
36. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
[TBL] [Abstract][Full Text] [Related]
37. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
Heath AB; Barrowcliffe TW
Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
39. Mesenterico left portal bypass for variceal bleeding owing to extrahepatic portal hypertension caused by portal vein thrombosis.
Ateş O; Hakgüder G; Olguner M; Seçil M; Karaca I; Akgür FM
J Pediatr Surg; 2006 Jul; 41(7):1259-63. PubMed ID: 16818059
[TBL] [Abstract][Full Text] [Related]
40. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk.
Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
Br J Haematol; 2010 Apr; 149(1):118-23. PubMed ID: 20096009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
